Can Biomarker-Based Monitoring Detect the Early Development of Diastolic Dysfunction During Chemotherapy?
- DOI
- 10.3390/medicina62091634
- Published
- 2026-08-26
- Container
- Medicina
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/medicina62091634,
title = {Can Biomarker-Based Monitoring Detect the Early Development of Diastolic Dysfunction During Chemotherapy?},
author = {Anca Daniela Farcaş and Cerasela Mihaela Goidescu and Mirela Anca Stoia and Florin Petru Anton and Andrada Viorica Pârvu and Camil Horia Eusebiu Crişan and Diana Larisa Mocan Hognogi},
year = {2026},
journal = {Medicina},
doi = {10.3390/medicina62091634},
url = {https://doi.org/10.3390/medicina62091634}
}RIS
TY - JOUR TI - Can Biomarker-Based Monitoring Detect the Early Development of Diastolic Dysfunction During Chemotherapy? AU - Anca Daniela Farcaş AU - Cerasela Mihaela Goidescu AU - Mirela Anca Stoia AU - Florin Petru Anton AU - Andrada Viorica Pârvu AU - Camil Horia Eusebiu Crişan AU - Diana Larisa Mocan Hognogi PY - 2026 JO - Medicina DO - 10.3390/medicina62091634 UR - https://doi.org/10.3390/medicina62091634 ER -
APA
Farcaş, A. D., Goidescu, C. M., Stoia, M. A., Anton, F. P., Pârvu, A. V., Crişan, C. H. E., & Hognogi, D. L. M. (2026). Can Biomarker-Based Monitoring Detect the Early Development of Diastolic Dysfunction During Chemotherapy?. Medicina. https://doi.org/10.3390/medicina62091634
Source records
- crossref · retrieved 2026-09-26T13:54:25.455Z